Coordination of tumor growth and host wasting by tumor-derived Upd3

Guangming Ding1, Xiaoxiang Xiang1, Yanhui Hu2

  • 1Department of Hepatobiliary and Pancreatic Surgery, Zhongnan Hospital of Wuhan University, Wuhan, Hubei 430071, PR China; Frontier Science Center for Immunology and Metabolism, Medical Research Institute, Wuhan University, Wuhan, Hubei 430071, PR China; Department of Oncology, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, PR China.

Cell Reports
|August 18, 2021
PubMed

Insights

Tumor growth in Drosophila causes host wasting by secreting Upd3, which activates the Jak/Stat pathway. This pathway impairs insulin signaling, leading to muscle dysfunction and energy imbalance, mimicking cancer cachexia.

Area of Science:

  • Molecular Biology
  • Genetics
  • Physiology

Background:

  • Drosophila yki-induced gut tumors cause host wasting, similar to human cancer cachexia.
  • Previous work identified tumor-derived ligands contributing to host wasting.

Purpose of the Study:

  • To identify molecular networks in host-tumor interactions.
  • To analyze major signaling pathways in Drosophila using the PathON tool.

Main Methods:

  • Development of PathON, a web-based tool for analyzing Drosophila signaling pathways.
  • Investigating the role of the Upd3/Jak/Stat axis in tumor-induced wasting.

Main Results:

  • The Upd3/Jak/Stat axis is a key modulator of host-tumor interactions.
  • Yki-gut tumors secrete Upd3, promoting tumor self-overproliferation and host wasting.
  • Upd3/Jak/Stat signaling in host organs upregulates ImpL2, inhibiting insulin signaling and energy balance.

Conclusions:

  • Yki-gut tumors utilize the Upd3/Jak/Stat pathway for both self-growth and host wasting.
  • This study reveals a novel mechanism linking tumor signaling to systemic metabolic disruption.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.7K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.0K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.1K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.0K